NFKB1 and Parkinson disease: This result is supported by other in vivo and in vitro studies that show NF-κB to be dysregulated and activated in PD (Baiguera et al., 2012; Liu et al., 2014; Parrella et al., 2019; Bellucci et al., 2020; Wang et al., 2020).